IL10 and neoplasm: Some researchers have identified a subpopulation of IL-10-releasing HMOX1 + myeloid cells that spatially localize to mesenchymal-like tumor regions, driving T-cell exhaustion and contributing to the immunosuppressive tumor microenvironment, as revealed by ST technology and other methods of integration.